info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

March, 2022, Volume 42, 3, pp 33592-33596

Review Article

Review Article

The Effect of Sodium Valproate on Cardiovascular Responses in Pentylenetetrazol Kindling Model of Epilepsy

Farzane Abaseynejad1, Rahim Akrami2,3, Reza Mohebbati4, Sajad Sehab Negah5,6, Payam Moharreri7, Mohammad Naser Shafey8, Mahdieh Shojaey9 and Mohammad Mohammad- Zadeh10*

Author Affiliations

1Student Research Committee, Mashhad University of Medical Sciences, Iran

2Department of epidemiology & biostatistics, School of public health, Sabzevar University of Medical Sciences, Iran

3Department of Epidemiology & Biostatistics, School of Public Health, Tehran University of Medical Sciences, Iran

4Applied Biomedical Research Center, Mashhad University of Medical Sciences, Iran

5Neuroscience Research Center, Mashhad University of Medical Sciences, Iran

6Department of Neurosciences, Mashhad University of Medical Sciences, Iran

7Department of Anatomy, Mashhad University of Medical Sciences, Iran

8Department of Physiology, Mashhad University of Medical Sciences, Iran

9Department of Physiology and Pharmacology, School of Medicine, Sabzevar University of Medical Sciences, Iran

10Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Iran

Received: February 25, 2022 | Published: March 08, 2022

Corresponding author: Mohammad Mohammad-Zadeh, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Iran and Clinical Research development Unit, Mashhad University of Medical Sciences, Mashhad, Iran

DOI: 10.26717/BJSTR.2022.42.006746

ABSTRACT

Sodium valproate acts as an anticonvulsant drug and is used for treatment of bipolar disorder. it has been reported that sodium valproate has effects on the cardiovascular system. Due to changes in blood pressure in epileptic patients, the aim of this study was to evaluate the effect of sodium valproate on blood pressure in epileptic rats. Fifty rats were divided into ten groups (5 per each group) in the following order: The groups 1-3 received saline (5, 10 and 15 times) every other day. Groups 4-6 were injected pentylenetetrazole (PTZ) (5, 10 and 15 times) thirty minutes after saline. Groups 7 to 9 were injected 30 minutes before PTZ valproate similar to groups 4-6. The tenth group received losartan (10 times) thirty minutes before PTZ every other day. All injections were intraperitoneal. Cardiovascular parameters were recorded in three time periods of fifth, tenth and fifteenth injections. The results showed that PTZ increased systolic and mean arterial blood pressure and sodium valproate returned these parameters to normal levels. Losartan (as an angiotensin II antagonist) reduced these parameters. The results showed that sodium valproate may reduce blood pressure in epileptics and its mechanisms may be related to reducing phosphorylation of the ERK (interfering with the angiotensin II receptor signaling pathway) However, more investigations on this topic are needed to clarify the mechanisms.

Keywords: Valproate; Kindling; Cardiovascular Function; High blood pressure

Introduction

Hypertension is one of the main causes of mortality and affects the financial burden of the health system in the world. Although the prevalence of epilepsy is not more than one to three percent, since one of the problems of people with epilepsy is high blood pressure (Gaitatzis, et al. [1]); Therefore, addressing this issue can be one of the priorities. In those people with epilepsy with high blood pressure (due to or unrelated to epilepsy), the simultaneous use of antihypertensive and anticonvulsant drugs is mandatory (Lukawski, et al. [2]). Epileptic seizures are associated with changes in the function of the cardiovascular system (Reeves, et al. [3]). During seizures caused by amygdala kindling, an increase in blood pressure has been reported along with a significant decrease in heart rate (Crawford, et al. [4,5]). Although there have been limited reports of ystolic and diastolic hypertension and heart rate in penicillin-induced seizures (Mameli, et al [6]), there have been numerous reports of hypertension and decreased heart rate after seizure (Lathers, et al. [7-10]). A study by Goodman et al. showed that blood pressure increased, and heart rate decreased significantly up to 30 minutes after amygdala kindling (Goodman, et al. [11]).

Valproic acid (VPA), a short-chain fatty acid extracted from Valerian officinalis, has been used as an anticonvulsant for decades around the world (Rajeshwari, et al. [12]). Valproic acid has been shown to lower blood pressure in spontaneusly hypertensive rats Cardinale et al. [13] and prevented high fat diet-induced hypertension (Choi, et al. [14]). On the other hand, it has been reported that one of the side effects of taking valproate is increased blood pressure and high heart rate (Sivananthan, et al. [15]). Due to the contradictory results of the effect of sodium valproate (VPA) on blood pressure; In this study, the role of VPA on the hypertension of epileptic rats was investigated by the kindling method (Figure 1).

Figure 1: Timeline diagram of experimental groups. Means penteylenetetrazol (PTZ) injection (all groups except groups 1-3). Means vehicle (groups 1-3) or valproate (groups 7-9) injection. The animals in groups 10 received Losartan (10 mg/kg) 30 min before PTZ injection. Groups 1, 4 and 7 received 5, groups 2, 5, 8, and 10 received 10 and groups 3, 6 and 9 received 15 PTZ injection.

Results

Data analysis demonstrated that systolic mean arterial pressure increased over time following PTZ injection (Figure 2A) [F (9, 38) = 17.20; P <0.001] was also drug-dependent, meaning that PTZ-induced hypertension was significantly reduced by VPA. Mean arterial pressure was increased significantly over time (Figure 2B) [F (9, 38) = 41.67; P <0.001] and as in systolic pressure under the influence of VPA this increase returned to the initial level and decreased significantly [F (9, 38) = 17.28; P <0.001]. Heart rate was another quantity that was evaluated in this study. Heart rate was recorded for 10 minutes in anesthetized animals after receiving the fifth, tenth and fifteenth drug / vehicle injections. One-way analysis of variance showed that this variable did not change significantly under the influence of pentylenetetrazol [F (9,38) = 0.6; P = 0.79]. VPA also failed to significantly change this parameter (Figure 3).

In another part of our study, losartan was used as a blood pressure lowering (positive control). The desired quantities (Mean arterial pressure, Systolic pressure and Heart rate) under the influence of this drug in a period of 10 injections statistical analyzed. Our data showed that: systolic pressure from 152.3 ± 7.8 in PTZ + vehicle group to 105.3±15.2 significantly decreased in PTZ + LRT group (P <0.05). Mean arterial pressure also decreased significantly from 137.1 ± 2.9 in PTZ + vehicle group to 76.3 ± 3.6 in PTZ + LRT group (P <0.05). But the heart rate did not change significantly (Figure 4).

Figure 2: A. Effect of PTZ and VPA on systolic blood pressure and

B. Mean arterial pressure during kindling acquisition.

The quantities were measured after the fifth, tenth and fifteenth PTZ injection. PTZ administration increased systolic blood pressure and mean arterial pressure time dependently and VPA reduce them to normal values. *** P<0.001 compared to respective vehicle group and $$$ P<0.001 when compared to respective PTZ group.

Figure 3: Effect of PTZ and VPA on heart rate during kindling acquisition. The quantities were measured after the fifth, tenth and fifteenth PTZ injection. PTZ administration and VPA injection did not change them relative to vehicle group.

Figure 4: Effect of PTZ, VPA and losartan (Lrt) on systolic blood pressure (Sys Pre), mean arterial pressure (MAP) and heart rate (HR) during kindling acquisition. The quantities were measured after the tenth PTZ injection. Losartan decrease MAP and systolic pressure but did not change heart rate. * P<0.05 compared to PTZ+vehicle group and $ P<0.05 when compared to PTZ+VPA group.

Discussion

Current findings demonstrated that in addition to causing seizures pentylenetetrazol increases the mean arterial pressure and systolic pressure. Valproate (VPA) as an anticonvulsant significantly reduces these two quantities. But the heart rate was not affected by pentylenetetrazol and VPA. Clinical seizures are associated with changes in the function of the cardiovascular system (Reeves, et al. [3]). During seizures caused by amygdala kindling, an increase in blood pressure has been reported along with a significant decrease in heart rate (Crawford, et al. [4,5]). Although there have been limited reports of systolic and diastolic hypertension and heart rate in penicillin-induced seizures (Mameli, et al. [6]), there have been numerous reports of hypertension and decreased heart rate after seizures (in different animal models of epilepsy) (Lathers, et al. [7-10]). A study by Goodman et al. showed increasing in blood pressure and significantly decreasing of heart rate up to 30 minutes after amygdala kindling. They showed that decreased heart rate was prevented by pretreatment with atropine and that hypertension was due to activation of alpha-adrenoceptors (Crawford IL, et al. [11]). The results of our study also showed that the mean arterial pressure and systolic pressure increase under the influence of pentylenetetrazol.

VPA through different ways has anticonvulsant effects. Delay in the return of voltage-dependent sodium channels to rest is one of these mechanisms. VPA reduces the synaptic transmission of glutamate (Zeise, et al. [16]) and increases GABA levels at the corresponding synapses by inhibiting GABA transaminase (Deckers, et al. [17]). On the other hand, GABA has been observed to play a protective role in hypertensive mice and significantly reduce blood pressure (Hayakawa, et al [18-20]). A clinical study also showed that sodium glutamate increased blood pressure (Shi, et al. [21]). In other words, lowering glutamate levels (by VPA) may lower blood pressure. In the present study, VPA probably significantly reduced mean arterial pressure and systolic pressure through one of these mechanisms. The lack of change in heart rate in this study as a result of PTZ and VPA injections may be due to the fact that the values were recorded in an unconscious state, in which case a change in the activity of the autonomic system could possibly affect the heart rate. Due to the fact that losartan in this study result in decrease in blood pressure caused by PTZ administration; it can be concluded that angiotensin 2 receptors may also be involved in increasing the blood pressure induced by PTZ.

Angiotensin leads to an increase in blood pressure by activating the ERK pathway in vascular smooth muscle cells (Sousa Lopes, et al. [22]). On the other hand, it has been shown that phosphorylation and ERK activation occur by angiotensin. Since the valproate cause reduction of ERK phosphorylation, it can be followed by a reduction in cardiac fibrosis caused by angiotensin (Zhang, et al. [23]). Therefore, it is possible that in the present study, valproate also reduced blood pressure by reducing ERK phosphorylation. However, measuring and determining the amount of ERK can confirm this claim and it is suggested that a study in this field to determine the exact mechanism of action of this anticonvulsant drug on blood pressure.

Acknowledgment

This work was done entirely at the Department of Physiology and was supported by a grant from Deputy of Research and Technology of Mashhahd University of Medical Sciences (#970139).

Conflict of Interests

None of the authors has any conflict of interest to disclose.

References

Review Article

The Effect of Sodium Valproate on Cardiovascular Responses in Pentylenetetrazol Kindling Model of Epilepsy

Farzane Abaseynejad1, Rahim Akrami2,3, Reza Mohebbati4, Sajad Sehab Negah5,6, Payam Moharreri7, Mohammad Naser Shafey8, Mahdieh Shojaey9 and Mohammad Mohammad- Zadeh10*

Author Affiliations

1Student Research Committee, Mashhad University of Medical Sciences, Iran

2Department of epidemiology & biostatistics, School of public health, Sabzevar University of Medical Sciences, Iran

3Department of Epidemiology & Biostatistics, School of Public Health, Tehran University of Medical Sciences, Iran

4Applied Biomedical Research Center, Mashhad University of Medical Sciences, Iran

5Neuroscience Research Center, Mashhad University of Medical Sciences, Iran

6Department of Neurosciences, Mashhad University of Medical Sciences, Iran

7Department of Anatomy, Mashhad University of Medical Sciences, Iran

8Department of Physiology, Mashhad University of Medical Sciences, Iran

9Department of Physiology and Pharmacology, School of Medicine, Sabzevar University of Medical Sciences, Iran

10Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Iran

Received: February 25, 2022 | Published: March 08, 2022

Corresponding author: Mohammad Mohammad-Zadeh, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Iran and Clinical Research development Unit, Mashhad University of Medical Sciences, Mashhad, Iran

DOI: 10.26717/BJSTR.2022.42.006746

ABSTRACT

Sodium valproate acts as an anticonvulsant drug and is used for treatment of bipolar disorder. it has been reported that sodium valproate has effects on the cardiovascular system. Due to changes in blood pressure in epileptic patients, the aim of this study was to evaluate the effect of sodium valproate on blood pressure in epileptic rats. Fifty rats were divided into ten groups (5 per each group) in the following order: The groups 1-3 received saline (5, 10 and 15 times) every other day. Groups 4-6 were injected pentylenetetrazole (PTZ) (5, 10 and 15 times) thirty minutes after saline. Groups 7 to 9 were injected 30 minutes before PTZ valproate similar to groups 4-6. The tenth group received losartan (10 times) thirty minutes before PTZ every other day. All injections were intraperitoneal. Cardiovascular parameters were recorded in three time periods of fifth, tenth and fifteenth injections. The results showed that PTZ increased systolic and mean arterial blood pressure and sodium valproate returned these parameters to normal levels. Losartan (as an angiotensin II antagonist) reduced these parameters. The results showed that sodium valproate may reduce blood pressure in epileptics and its mechanisms may be related to reducing phosphorylation of the ERK (interfering with the angiotensin II receptor signaling pathway) However, more investigations on this topic are needed to clarify the mechanisms.

Keywords: Valproate; Kindling; Cardiovascular Function; High blood pressure